These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 12354694

  • 1. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.
    Hajitou A, Grignet C, Devy L, Berndt S, Blacher S, Deroanne CF, Bajou K, Fong T, Chiang Y, Foidart JM, Noël A.
    FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A, Sounni NE, Devy L, Grignet-Debrus C, Lewalle JM, Li H, Deroanne CF, Lu H, Colige A, Nusgens BV, Frankenne F, Maron A, Yeh P, Perricaudet M, Chang Y, Soria C, Calberg-Bacq CM, Foidart JM, Noël A.
    Cancer Res; 2001 Apr 15; 61(8):3450-7. PubMed ID: 11309307
    [Abstract] [Full Text] [Related]

  • 3. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K, Saishin Y, Saishin Y, Silva RL, Oshima Y, Oshima S, Melia M, Paszkiet B, Zerby D, Kadan MJ, Liau G, Kaleko M, Connelly S, Luo T, Campochiaro PA.
    FASEB J; 2003 May 15; 17(8):896-8. PubMed ID: 12670875
    [Abstract] [Full Text] [Related]

  • 4. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
    Ding I, Sun JZ, Fenton B, Liu WM, Kimsely P, Okunieff P, Min W.
    Cancer Res; 2001 Jan 15; 61(2):526-31. PubMed ID: 11212245
    [Abstract] [Full Text] [Related]

  • 5. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X, Kanwar JR, Leung E, Lehnert K, Wang D, Krissansen GW.
    Cancer Gene Ther; 2001 Oct 15; 8(10):719-27. PubMed ID: 11687895
    [Abstract] [Full Text] [Related]

  • 6. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K.
    Hepatology; 2003 Mar 15; 37(3):696-704. PubMed ID: 12601367
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
    Hampl M, Tanaka T, Albert PS, Lee J, Ferrari N, Fine HA.
    Hum Gene Ther; 2001 Sep 20; 12(14):1713-29. PubMed ID: 11560766
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
    Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, Tisato V, Roni V, Esposito G, Morini M, Albini A, Noonan DM, Ferrantini M, Amadori A, Chieco-Bianchi L.
    Gene Ther; 2002 Jul 20; 9(13):867-78. PubMed ID: 12080381
    [Abstract] [Full Text] [Related]

  • 9. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.
    Calvo A, Feldman AL, Libutti SK, Green JE.
    Cancer Res; 2002 Jul 15; 62(14):3934-8. PubMed ID: 12124322
    [Abstract] [Full Text] [Related]

  • 10. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy.
    Nguyen JT, Wu P, Clouse ME, Hlatky L, Terwilliger EF.
    Cancer Res; 1998 Dec 15; 58(24):5673-7. PubMed ID: 9865720
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation.
    Yin YJ, Salah Z, Maoz M, Even Ram SC, Ochayon S, Neufeld G, Katzav S, Bar-Shavit R.
    FASEB J; 2003 Feb 01; 17(2):163-74. PubMed ID: 12554695
    [Abstract] [Full Text] [Related]

  • 16. Development of lentiviral vectors for antiangiogenic gene delivery.
    Shichinohe T, Bochner BH, Mizutani K, Nishida M, Hegerich-Gilliam S, Naldini L, Kasahara N.
    Cancer Gene Ther; 2001 Nov 01; 8(11):879-89. PubMed ID: 11773978
    [Abstract] [Full Text] [Related]

  • 17. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA, Smith R, Pathak A, Schloss D, Lum B, Cao Y, Johnson F, Engleman EG, Nolan GP.
    Mol Ther; 2001 Feb 01; 3(2):186-96. PubMed ID: 11237675
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A, Yokoyama Y, Smith LE, Ali I, Shih SC, Feldman AL, Libutti SK, Sundaram R, Green JE.
    Int J Cancer; 2002 Sep 20; 101(3):224-34. PubMed ID: 12209972
    [Abstract] [Full Text] [Related]

  • 19. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
    Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.
    Cancer Res; 2003 Jun 15; 63(12):3403-12. PubMed ID: 12810677
    [Abstract] [Full Text] [Related]

  • 20. [Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].
    Wang F, Tian YH, Li L, Chen XF, Hu HH, Li CY, Huang Q.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar 15; 34(2):165-70. PubMed ID: 12006990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.